학술논문
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial
Document Type
Article
Author
Beelen, Dietrich Wilhelm ; Trenschel, Rudolf; Stelljes, Matthias; Groth, Christoph; Masszi, Tamás; Reményi, Péter; Wagner-Drouet, Eva-Maria; Hauptrock, Beate; Dreger, Peter; Luft, Thomas; Bethge, Wolfgang; Vogel, Wichard; Ciceri, Fabio; Peccatori, Jacopo; Stölzel, Friedrich; Schetelig, Johannes; Junghanß, Christian; Grosse-Thie, Christina; Michallet, Mauricette; Labussiere-Wallet, Hélène; Schaefer-Eckart, Kerstin; Dressler, Sabine; Grigoleit, Goetz Ulrich; Mielke, Stephan; Scheid, Christof; Holtick, Udo; Patriarca, Francesca; Medeot, Marta; Rambaldi, Alessandro; Micò, Maria Caterina; Niederwieser, Dietger; Franke, Georg-Nikolaus; Hilgendorf, Inken; Winkelmann, Nils Rudolf; Russo, Domenico; Socié, Gérard; Peffault de Latour, Régis; Holler, Ernst; Wolff, Daniel; Glass, Bertram; Casper, Jochen; Wulf, Gerald; Menzel, Helge; Basara, Nadezda; Bieniaszewska, Maria; Stuhler, Gernot; Verbeek, Mareike; Grass, Sandra; Iori, Anna Paola; Finke, Juergen; Benedetti, Fabio; Pichlmeier, Uwe; Hemmelmann, Claudia; Tribanek, Michael; Klein, Anja; Mylius, Heidrun Anke; Baumgart, Joachim; Dzierzak-Mietla, Monika; Markiewicz, Miroslaw
Source
In The Lancet Haematology January 2020 7(1):e28-e39
Subject
Language
ISSN
2352-3026